DCPH — Deciphera Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.21bn
- $1.94bn
- $163.36m
Deciphera Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
U.S. RESEARCH ROUNDUP- Arista Networks, Credit Acceptance, Tractor Supply
U.S. STOCKS ON THE MOVE-SeaStar, SJW Group, Pinterest
U.S. STOCKS ON THE MOVE-Crypto, Miromatrix Medical, US banks
U.S. STOCKS ON THE MOVE-JinkoSolar, Reviva, MeiraGTx
Deciphera surges on Q3 revenue beat
Brief: Deciphera Pharmaceuticals Q3 Basic EPS USD -0.58
Deciphera Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Deciphera Pharmaceuticals Q2 Basic EPS USD -0.57
Deciphera Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Deciphera Pharmaceuticals Announces Appointment Of Dashyant Dhanak, Ph.D., As Executive Vice President
Deciphera Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Deciphera Pharmaceuticals Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing
Deciphera Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
Deciphera Pharmaceuticals Inc expected to post a loss of 59 cents a share - Earnings Preview
Brief: Deciphera Pharmaceuticals Announces FDA Grants Breakthrough Therapy Designation For Qinlock In Second-Line Gist Patients With Mutations In Kit Exon 11 And 17/18
Brief: Deciphera Pharmaceuticals Announces Completion Of Enrollment For Pivotal Phase 3 Motion Study Of Vimseltinib In Tgct
U.S. RESEARCH ROUNDUP-BP, Chipotle Mexican Grill, Hain Celestial Group